AI医疗成像分析公司Elucid近日宣布，已筹集8000万美元的C轮融资。本轮融资由Elevage Medical Technologies领投。Elucid是一家领先的医疗技术公司，为医生提供人工智能驱动的成像分析软件来评估心血管疾病。该公司使用AI技术来分析医学影像，以协助医生更准确地诊断和治疗疾病。此次融资将用于继续开发其产品，并扩大其全球市场份额。
Elucid成立于2016年，致力于为医疗保健行业带来创新和先进的AI技术。该公司的产品已被广泛应用于世界各地的医院和诊所，并获得了多项国际奖项和认可。此次融资将帮助Elucid继续巩固其领先地位，并加速其在全球范围内的扩张。
Elevage Medical Technologies是一家专注于医疗保健领域的投资公司，致力于支持创新医疗技术的发展。该公司在医疗保健领域有多年的投资经验，曾参与过多个医疗技术公司的投资和并购。
此次融资的消息得到了Elucid的创始人兼CEO XXXX的认可。他表示：“我们很高兴能够筹集到8000万美元的C轮融资，这证明了我们的产品在医疗保健市场上的潜力。我们将继续致力于创新和发展，为全球医生和患者提供最好的产品和服务。”
AI医疗成像分析是当前医疗技术领域的一个热门领域，其应用范围广泛，包括医学影像诊断、药物研发、病理分析等。Elucid的成功证明了AI医疗成像分析公司的巨大潜力。随着人工智能技术的不断发展和普及，未来AI医疗成像分析有望成为医疗保健领域的重要工具。
新闻翻译：
Title: AI medical imaging analysis company Elucid receives $80 million C round of financing, led by Elevage Medical Technologies
Keywords: AI medical imaging analysis, Elucid, financing, Elevage Medical Technologies
News content:
AI medical imaging analysis company Elucid recently announced that it has raised $80 million in a C round of financing. This round of financing was led by Elevage Medical Technologies. Elucid is a leading medical technology company that provides doctors with AI-driven imaging analysis software to evaluate cardiovascular diseases. The company uses AI technology to analyze medical images to assist doctors in making more accurate diagnoses and treatments. The financing will be used to continue developing its products and expanding its global market share.
Elucid was founded in 2016 and is dedicated to bringing innovation and advanced AI technology to the healthcare industry. Its products have been widely used in hospitals and clinics around the world and have received several international awards and recognitions. This financing will help Elucid solidify its leading position and accelerate its global expansion.
Elevage Medical Technologies is a venture capital firm specializing in the healthcare industry, dedicated to supporting the development of innovative medical technologies. The company has extensive experience in investing in and acquiring medical technology companies in the healthcare sector.
The financing的消息得到了Elucid的创始人兼CEO XXXX的认可。他表示：“我们很高兴能够筹集到8000万美元的C轮融资，这证明了我们的产品在医疗保健市场上的潜力。我们将继续致力于创新和发展，为全球医生和患者提供最好的产品和服务。”
AI medical imaging analysis is a popular field in the current medical technology sector, with applications ranging from medical image diagnosis, drug development, to pathological analysis. Elucid’s success demonstrates the huge potential of AI medical imaging analysis companies. With the continuous development and popularization of artificial intelligence technology, AI medical imaging analysis is expected to become an important tool in the healthcare industry in the future.
【来源】https://www.businesswire.com/news/home/20231109116167/en/Elucid-Raises-80-Million-in-Series-C-Round-Led-by-Elevage-Medical-Technologies
Views: 2